DONATE

Publications

Access IBEC scientific production portal (IBEC CRIS), for more detailed information and advanced search features.

Find here the list of all IBEC's publications by year.

by Keyword: Parkinsons-disease

Carballo-Molina, Oscar A, Kolberg-Edelbrock, Alexandra N, Alvarez-Saavedra, Matias, Alvarez, Zaida, Fyrner, Timmy, Perez-Rosello, Tamara, Syrgiannis, Zois, Chin, Stacey M, Takata, Nozomu, Strong, Madison, Palmer, Liam C, James Surmeier, D, Stupp, Samuel I, (2025). Supramolecular nanostructure mimics GDNF trophic effects in vitro on human dopaminergic neurons npj Regenerative Medicine 10, 37

Peptide-based supramolecular nanostructures offer a versatile platform with substantial promise for clinical translation in regenerative medicine. These systems allow for the incorporation of biologically active sequences and can be engineered to modulate tissue-specific parameters such as stiffness, diffusivity, and biodegradability. We developed here a bioactive supramolecular nanostructure containing a peptide designed based on glial cell-derived neurotrophic factor. These nanostructures form scaffolds that mimic important trophic effects provided by this growth factor on iPSC-derived human dopaminergic neurons. Our in vitro data show that the nanostructures promote cell viability, confer neuroprotection against 6-hydroxydopamine toxicity, enhance neuronal morphology, facilitate electrophysiological maturation, and induce genes involved in neuronal survival. We also found that the scaffold promoted axonal extension in midbrain human organoids. These findings suggest that the supramolecular system could be useful to improve outcomes in cell-based therapies for Parkinson's disease, where progressive dopaminergic degeneration is a hallmark.

JTD Keywords: Cell-line, Mouse model, Neural transplantation, Neurite outgrowth, Neurotrophic factor, Parkinsons-disease, Rat model, Re, Receptor, Substantia-nigra


Molina, BG, Arnau, M, Sánchez, M, Alemán, C, (2024). Controlled dopamine release from cellulose-based conducting hydrogel EUROPEAN POLYMER JOURNAL 202, 112635

Very recently, the controlled release of dopamine (DA), a neurotransmitter whose deficiency is associated with Parkinson's disease, has been postulated as a good alternative to the oral administration of levodopa (L-Dopa), a dopamine precursor, to combat the effects of said disease. However, this is still a very little explored field and there are very few carriers that are capable of releasing DA, a small and water-soluble molecule, in an efficient and controlled manner. In this work, we report a carrier based on a conductive hydrogel capable of loading DA and releasing it progressively and efficiently (100 % release) in a period of five days by applying small electrical stimuli (-0.4 V) daily for a short time (1 min). The hydrogel (CMC/PEDOT), which is electrically active, has been prepared from sodium carboxymethylcellulose and poly(3,4-ethylenedioxythiophene) microparticles, using citric acid as a cross-linking agent. Furthermore, the results have shown that when relatively hydrophobic small molecules, such as chloramphenicol, are loaded, the electrostimulated release is significantly less efficient, demonstrating the usefulness of CMC/PEDOT as a carrier for neurotransmitters.

JTD Keywords: Amines, Carboxymethyl cellulose, Carboxymethylcellulose, Conducting hydrogels, Conducting polymers, Controlled release, Crosslinking, Dopamine, Drug-delivery system, Electrostimulation, Hydrogels, Joining, Levodopa, Loading, Molecules, Neurophysiology, Neurotransmitter release, Neurotransmitters release, Oral administration, Parkinson's disease, Parkinsons-disease, Poly(3,4-ethylenedioxythiophene), Release, Sodium, Transport, Water-soluble molecule